News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for Ongoing Placebo-Controlled Clinical Trial
Jaguar Health submits amended protocol to FDA for crofelemer in pediatric MVID patients to potentially extend lives and reduce parenteral support by up to 37% -
-
-
COMMUNIQUÉ DE PRESSE
Kolmar Korea Named Among TIME's World's Best Companies in Sustainable Growth 2026 for the Second Consecutive Year
Kolmar Korea named among TIME's World's Best Companies in Sustainable Growth 2026 for the second consecutive year, showcasing leadership in eco-friendly innovation and responsible growth -
COMMUNIQUÉ DE PRESSE
iDEAL Semiconductor Sets New Safety Level for High-Voltage Batteries with SuperQ™ MOSFETs
iDEAL Semiconductor introduces SuperQ™ MOSFET technology for high-voltage batteries, setting new safety standards with superior short-circuit robustness and reduced component count. The new platform promises enhanced reliability and cost savings for battery management systems
